Europe - Frankfurt Stock Exchange - FRA:2M6 - IE00BTN1Y115 - Common Stock
The current stock price of 2M6.DE is 82.96 EUR. In the past month the price decreased by -8.33%. In the past year, price increased by 7.1%.
Symbol | Company Name | TA | FA | PE | Market Cap |
|---|---|---|---|---|---|
| SHL.DE | SIEMENS HEALTHINEERS AG | 18.62 | 50.20B | ||
| PHI1.DE | KONINKLIJKE PHILIPS NV | 15.41 | 21.95B | ||
| PHIA.AS | KONINKLIJKE PHILIPS NV | 15.36 | 21.90B | ||
| BIM.PA | BIOMERIEUX | 28.5 | 13.02B | ||
| OBCK.DE | OTTOBOCK SE & CO KGAA | 137.87 | 4.15B | ||
| DIA.MI | DIASORIN SPA | 20.13 | 3.73B | ||
| AFX.DE | CARL ZEISS MEDITEC AG - BR | 25.03 | 3.60B | ||
| DRW3.DE | DRAEGERWERK AG - PREF | 10.6 | 1.28B | ||
| ELN.MI | EL.EN. SPA | 21.7 | 1.12B | ||
| DRW8.DE | DRAEGERWERK AG | 8.84 | 1.07B | ||
| EUZ.DE | ECKERT & ZIEGLER SE | 23.03 | 950.89M | ||
| GVS.MI | GVS SPA | 42.72 | 727.40M |
Medtronic Plc is a medical technology company, which engages in the development, manufacture, distribution, and sale of device-based medical therapies and services. The company is headquartered in Galway, Connacht and currently employs 95,000 full-time employees. The Company’s products category includes Advanced Surgical Technology; Cardiac Rhythm; Cardiovascular; Digestive & Gastrointestinal; Ear, Nose & Throat; General Surgery; Gynecological; Neurological; Oral & Maxillofacial; Patient Monitoring; Renal Care; Respiratory; Spinal & Orthopedic; Surgical Navigation & Imaging; Urological; Product Manuals; Product Ordering & Inquiries; and Product Performance & Advisories. Its products include Cardiac Implantable Electronic Device (CIED) Stabilization, Aortic Stent Graft Products, CareLink Personal Therapy Management Software, CareLink Pro Therapy Management Software. Its services and solutions include Ambulatory Surgery Center Resources, Care Management Services, Digital Connectivity Information Technology (IT) Support, Equipment Services and Support, Innovation Lab, Medtronic Healthcare Consulting, and Office-Based Sinus Surgery.
MEDTRONIC PLC
Building Two Parkmore Business Park West
GALWAY CONNACHT IE
Employees: 95000
Phone: 35314381700
Medtronic Plc is a medical technology company, which engages in the development, manufacture, distribution, and sale of device-based medical therapies and services. The company is headquartered in Galway, Connacht and currently employs 95,000 full-time employees. The Company’s products category includes Advanced Surgical Technology; Cardiac Rhythm; Cardiovascular; Digestive & Gastrointestinal; Ear, Nose & Throat; General Surgery; Gynecological; Neurological; Oral & Maxillofacial; Patient Monitoring; Renal Care; Respiratory; Spinal & Orthopedic; Surgical Navigation & Imaging; Urological; Product Manuals; Product Ordering & Inquiries; and Product Performance & Advisories. Its products include Cardiac Implantable Electronic Device (CIED) Stabilization, Aortic Stent Graft Products, CareLink Personal Therapy Management Software, CareLink Pro Therapy Management Software. Its services and solutions include Ambulatory Surgery Center Resources, Care Management Services, Digital Connectivity Information Technology (IT) Support, Equipment Services and Support, Innovation Lab, Medtronic Healthcare Consulting, and Office-Based Sinus Surgery.
The current stock price of 2M6.DE is 82.96 EUR. The price decreased by -0.2% in the last trading session.
MEDTRONIC PLC (2M6.DE) has a dividend yield of 2.92%. The yearly dividend amount is currently 2.35.
2M6.DE has a ChartMill Technical rating of 3 out of 10 and a ChartMill Fundamental rating of 5 out of 10.
The PE ratio for MEDTRONIC PLC (2M6.DE) is 17.36. This is based on the reported non-GAAP earnings per share of 4.78 and the current share price of 82.96 EUR.
The Revenue of MEDTRONIC PLC (2M6.DE) is expected to grow by 7.65% in the next year. Check the estimates tab for more information on the EPS, Sales, EBIT and EBITDA future analyst estimates.
MEDTRONIC PLC (2M6.DE) has a market capitalization of 106.36B EUR. This makes 2M6.DE a Large Cap stock.
ChartMill assigns a technical rating of 3 / 10 to 2M6.DE. When comparing the yearly performance of all stocks, 2M6.DE turns out to be only a medium performer in the overall market: it outperformed 55.23% of all stocks.
ChartMill assigns a fundamental rating of 5 / 10 to 2M6.DE. 2M6.DE has an average financial health and profitability rating.
Over the last trailing twelve months 2M6.DE reported a non-GAAP Earnings per Share(EPS) of 4.78. The EPS increased by 7.24% compared to the year before.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PM (TTM) | 13.71% | ||
| ROA | 5.22% | ||
| ROE | 9.79% | ||
| Debt/Equity | 0.57 |
39 analysts have analysed 2M6.DE and the average price target is 96 EUR. This implies a price increase of 15.72% is expected in the next year compared to the current price of 82.96.
For the next year, analysts expect an EPS growth of 3.64% and a revenue growth 7.65% for 2M6.DE